KERVALION, a company focused on developing advanced 3D-printed bone grafts, has successfully secured $416,000 in a recent funding round from investors. This capital infusion marks a significant milestone for the company as it continues to innovate in the field of personalized medical solutions.
The company specializes in creating custom-designed bone grafts from patient scans, initially targeting pre-implant dental surgery. These grafts are engineered to treat bone deficiencies that often prevent the successful placement of dental implants. By leveraging personalized manufacturing, KERVALION's grafts offer a precise fit in both shape and volume, which simplifies surgical procedures and can reduce the number of interventions required for patients. The innovative material used in these grafts ensures excellent biocompatibility and promotes reliable bone regeneration.
This investment underscores confidence in KERVALION's pioneering approach to addressing critical needs in dental surgery. The newly secured capital is earmarked to accelerate product development, expand manufacturing capabilities, and support market entry initiatives. This funding will enable KERVALION to further refine its technology and scale its operations to meet growing demand.
KERVALION's technology aims to provide practitioners with an easier, faster, and more cost-effective solution for bone grafting, thereby making advanced procedures accessible to a wider range of dental professionals while significantly improving patient comfort and outcomes. With this funding, KERVALION is poised to further establish its presence in the dental and medical device sectors, aiming to make advanced bone grafting solutions more accessible and efficient for practitioners and patients alike, driving innovation in regenerative medicine.
